- The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
- Find out how study types differ in our How to read a paper section.
- Impact factor latest: The BMJ's impact factor is now 17.215. Submit your paper to the world's fourth most cited general medical journal.
- OPEN ACCESS: All research articles are freely available online, with no word limit. Find out more about the BMJ's open access policy. Submit your paper.
- Keep up to date with diabetes: Access the latest diabetes resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
- Keep up to date with cardiology: Access the latest cardiovascular medicine resources from across BMJ Group.
- Hot topics: We regularly publish more than one article on the same subject simultaneously. Find out more on our article clusters page.
- Dementia: Access the latest dementia resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
- Neurology updates: Access the latest neurology resources from BMJ Group, including articles, learning modules, podcasts, and blogs.
- Infectious diseases: Access the latest infectious disease resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
- Updates from bmj.com: Get RSS feeds of latest articles published at bmj.com/rss
Elizabeth Loder, M.D., M.P.H., received an undergraduate biology degree from Harvard College, studied medicine at the University of North Dakota, and received a master’s degree in public health from the University of Massachusetts. She is the BMJ's clinical epidemiology editor. She divides her time between the BMJ and her position as chief of the Division of Headache and Pain in the Department of Neurology at Brigham and Women’s Hospital, Boston. Dr. Loder is an associate professor of neurology at Harvard Medical School, and is board certified in internal medicine and headache medicine. She is the current President of the American Headache Society and has held leadership positions in national and international pain organizations; most recently, she served as a member of the Institute of Medicine’s Committee on Advancing Pain Research, Care, and Education.
Dr. Loder has worked as a clinician and researcher in the headache field for many years, and has extensive experience in the design and conduct of clinical trials. As a result of these experiences, Dr. Loder is deeply interested in problems associated with clinical trial reporting and interpretation, especially the consequences of missing clinical trial information for guidelines and treatment decisions. She has devoted much of her recent career to the development, implementation, and dissemination of standards for research reporting. She was responsible for a recent BMJ theme issue on unpublished clinical trial data. Research published in that issue of the journal has led several US lawmakers to question whether the NIH and FDA are doing enough to enforce research reporting requirements.
Have you in the past five years accepted the following from an organisation that may in any way gain or lose financially from the publication of papers in the BMJ
Reimbursement for attending a symposium?
Yes, I have been reimbursed by many professional organisations for expenses incurred in attending symposia, meetings or courses, generally in connection with a speaking engagement or board meeting.
A fee for speaking?
Yes, I have received honoraria for lectures on topics relating to headache and pain from pharmaceutical companies, academic institutions, and professional organisations and associations. At present I speak only at academic and professional meetings and when offered I do accept speaking fees for these talks.
A fee for organising education?
Funds for research?
Yes, I have been an investigator in many clinical trials of headache treatments funded by pharmaceutical or device companies. As a hospital employee, I do not directly receive research money; the hospital contracts with the company and then pays me for my work on the trial from those funds.
Funds for a member of staff?
Fees for consulting?
Yes, I have received fees for consulting from academic organisations, such as the Thomas Jefferson Office of Health Policy, and from professional organisations such as the American Headache Society or National Headache Foundation for consulting on specific educational or research projects. I have received consulting fees from medical education, pharmaceutical or medical device companies for consulting or serving on advisory boards related to product development, research design, and marketing.
Have you in the past five years been employed by any organisation that may in any way gain or lose financially from the publication of papers in the BMJ?
Yes, I have been an employee of the Spaulding Rehabilitation Hospital and now am an employee of the Brigham and Women's Hospital in Boston, Massachusetts. Both are members of Partners Healthcare Network, a non-profit healthcare corporation. Partners and its institutions are heavily involved in medical research and Partners benefits from the publication success of its researchers.
Do you hold any stocks or shares in an organisation?
Yes, I have shares or stock in many companies and mutual funds and a family trust. None of these investments involves drug, medical device or health care companies.
Do you have any other competing financial interests?
My husband is a partner in a law firm that provides services to many clients in the healthcare field, but his work does not involve healthcare.
I have no competing interests/I have the following competing interests?
I serve as an associate editor (unpaid) for the journal Headache. I am active in the International Headache Society and the American Headache Society.